Replies to post #28267 on Biotech Values

[DewDiligence]

> AGN did spend $230M for Oculex so it's nice to see the technology may have some use after all.<

The Posurdex program in DME is pretty far along, so AGN could yet derive some decent value from the Oculex deal. They don’t talk much about Posurdex, however; mainly, they mention it only when asked.